| Mrs Barbara Warren Shirer, BARBARA | |
|
1106 John C Calhoun Dr, Orangeburg, SC 29115-6656 | |
| (803) 531-2079 | |
| Not Available |
| Full Name | Mrs Barbara Warren Shirer |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1106 John C Calhoun Dr, Orangeburg, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831471390 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6078 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Barbara Warren Shirer, BARBARA 1106 John C. Calhoun Dr, Orangeburg, SC 29115 Ph: (803) 531-2079 | Mrs Barbara Warren Shirer, BARBARA 1106 John C Calhoun Dr, Orangeburg, SC 29115-6656 Ph: (803) 531-2079 |
News Archive
A solar eclipse doesn't occur every day, so it's good to be reminded how to watch one safely. Wichita State University's Greg Novacek offers the following tips on how to watch a solar eclipse safely.
Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor™ is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).
Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer. The compound is being developed by its wholly-owned subsidiary, Antigen Express, Inc.
Consuming grapes twice a day for six months protected against significant metabolic decline in Alzheimer-related areas of the brain in a study of people with early memory decline.
› Verified 3 days ago
Mr. Earle Patrick Barton, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Saint Matthews Rd, Orangeburg, SC 29118 Phone: 803-395-2226 Fax: 803-395-2990 | |
Javery Brian Santwire, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3310 Magnolia St, Orangeburg, SC 29115 Phone: 803-531-6900 | |
Trung Ngo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1106 John C Calhoun Dr, Orangeburg, SC 29115 Phone: 803-531-2079 | |
Mrs. Karla Jones Glover, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2795 North Rd, Orangeburg, SC 29118 Phone: 803-531-1586 Fax: 803-533-7300 | |
Mosunmola Feyisara Filani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1535 John C Calhoun Dr, Orangeburg, SC 29115 Phone: 803-534-0521 Fax: 803-535-3211 | |
Sabrina Valentine, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2795 North Rd, Orangeburg, SC 29118 Phone: 803-533-7300 Fax: 803-533-0819 | |
Holly Hartzog, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2195 Magnolia St, Orangeburg, SC 29115 Phone: 803-533-1390 |